Conclusions Newer anti-obesity medications demonstrate differential associations with ocular outcomes compared to traditional agents
According to Raj Singh, MD, FACP, FASN , an internal medicine specialist, nephrologist, and obesity medicine specialist at Healor Health, people taking GLP-1s should expect to stay on them long-term or even indefinitely
Your provider may recommend a slower schedule or a lower maintenance dose
Some patients report losing 50, 80, or even more than 100 pounds while staying on lower doses for months
Sleep quality deserves attention during treatment
They also slow down how quickly food leaves your stomach (called gastric emptying)